株式会社極東書店トップ＞商品一覧＞ Receptor - Based Drug Design.

商品詳細

Name: Receptor - Based Drug Design.
Price: 53856 JPY
Availability: BackOrder
Author: Leff, Paul (ed.)
ISBN: 978-0-8247-0162-8

Receptor - Based Drug Design.

・ISBN 978-0-8247-0162-8 hard GB£ 170.00

￥53,856.- (税込) ※（※）価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。

お気に入り ★★★

カートに入れる

電子版あり大学・学術機関向け電子ブック（eBook）ISBN 9780429121326

電子ブックの価格を見る

著者・編者	Leff, Paul (ed.),
出版社	(CRC Press Inc, US)
出版年月	1998
ページ数	400 pp.
言語	ENG
ニュース番号	＜A00-35071＞

解説

Employing a wide range of examples from G-protein-coupled receptors and ligand-gated ion channels, this detailed, single-source reference illustrates the principles of pharmacological analysis and receptor classification that are the basis of rational drug design.
Explains the experimental and theoretical methods used to characterize interactions between ligands and receptors-providing the pharmacological information needed to solve treatment problems and facilitate the drug design process!
Demonstrating the achievements of the receptor-based approach in therapeutics and indicating future directions, Receptor-Based Drug Design

introduces novel computer-assisted strategies for the design of new agonists, antagonists, and inverse agonists for G-protein-coupled receptors

shows how to assess agonist concentration-effect curve data

discusses radioligand binding assays

presents new in vitro multiarray assays for G-protein-coupled receptors

explains the use of individual second messenger signaling responses in analyzing drug-receptor interactions

examines the role of electrophysiology in finding new drugs and drug targets

describes selectively acting b-adrenoceptor agonists and glucocorticoid steroids for asthma treatment

outlines the rationale for using angiotensin receptor antagonists

and more!
Written by over 25 international authorities and containing nearly 1200 bibliographic citations, Receptor-Based Drug Design is a practical resource for pharmacologists, pharmacists, and pharmaceutical scientists; organic and medicinal chemists and biochemists; molecular biologists; biomedical researchers; and upper-level undergraduate and graduate students in these disciplines.